Biocept, Inc. (NASDAQ:BIOC)

About the company

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

88

CEO

Michael W. Nall

Exchange

NASDAQ

Website

http://www.biocept.com

$6.00M

Total Revenue

88

Employees

$25.08M

Market Capitalization

-0.92

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$-5M

Operating Margin (in %)

Total operating margin

$-24M

Net Margin (in %)

Total net margin

$-28M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11671.20 11487.00 5.07 12.95 7.85
Chemed Corp. CHE 7945.12 1992.00 10.85 33.41 11.60
Guardant Health, Inc. GH 7770.15 245.00 10.52 -100.66 -31.53
Amedisys, Inc. AMED 6736.62 1980.00 9.73 53.02 6.43
LHC Group, Inc. LHCG 5518.93 2091.00 3.93 56.16 4.73
1Life Healthcare, Inc. ONEM 4576.32 292.00 9.84 -57.65 -27.31
NeoGenomics, Inc. NEO 3591.28 419.00 7.37 847.00 0.82
Natera, Inc. NTRA 3509.84 330.00 14.61 -28.28 -38.27
SmileDirectClub, Inc. SDC 3118.50 769.00 9.88 -25.31 -16.02
Invitae Corp. NVTA 3045.12 241.00 12.15 -9.97 -125.90
The Ensign Group, Inc. ENSG 2381.12 2155.00 3.38 19.24 5.76
Acadia Healthcare Co., Inc. ACHC 2210.56 3130.00 0.91 19.63 3.61
MEDNAX, Inc. MD 1451.67 3508.00 1.00 -1.14 -36.30
Addus HomeCare Corp. ADUS 1289.96 598.00 3.05 62.68 3.33
U.S. Physical Therapy, Inc. USPH 1051.18 478.00 4.31 35.78 6.03
RadNet, Inc. RDNT 791.50 1164.00 6.46 395.75 0.18
Castle Biosciences, Inc. CSTL 665.04 61.00 7.72 652.00 9.75
The Pennant Group, Inc. PNTG 640.64 352.00 8.38 152.53 1.19
Option Care Health, Inc. OPCH 636.00 2539.00 2.69 -6.50 -3.63
Hanger, Inc. HNGR 612.18 1095.00 -38.36 32.88 1.71
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 440.13 41.00 -16.08 -14.15 -74.67
Fulgent Genetics, Inc. FLGT 324.20 35.00 4.32 -1621.00 -1.31
OptiNose, Inc. OPTN 277.35 37.00 8.38 -2.52 -295.66
American Renal Associates Holdings, Inc. ARA 205.12 824.00 -2.54 -11.45 -2.19
Aptinyx, Inc. APTX 179.64 4.00 1.86 -3.22 -810.48
Exagen, Inc. XGN 170.30 41.00 3.28 -5.33 -76.21
CRH Medical Corp. CRHM 164.62 117.00 2.17 112.75 1.52
Pro-Dex, Inc. PDEX 70.68 31.00 3.93 16.06 14.50
Guardion Health Sciences, Inc. GHSI 36.63 1.00 2.69 -1.60 -824.43
Cardiff Oncology, Inc. CRDF 33.32 0.00 13.60 -2.17 -883.77
OncoSec Medical, Inc. ONCS 26.00 None 2.13 -0.69 None
Biocept, Inc. BIOC 25.08 6.00 3.88 -0.92 -463.58
Capital Senior Living Corp. CSU 21.36 439.00 -0.68 -0.31 -16.00
American Shared Hospital Services AMS 12.42 20.00 0.45 51.75 1.28
IMAC Holdings, Inc. IMAC 10.98 16.00 1.26 -1.63 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Biocept Awarded Canadian Patent Covering Enhanced Detection Of Rare Cells

2d ago, source: Reuters

BIOCEPT AWARDED CANADIAN PATENT COVERING THE ENHANCED DETECTION OF RARE CELLS, INCLUDING CANCER CELLS, FROM A BIOLOGICAL FLUID SAMPLE SUCH AS BLOOD OR CEREBROSPINAL FLUID * BIOCEPT INC - AWARDED ...

Biocept (NASDAQ:BIOC) Shares Gap Up to $0.71

11h ago, source: theenterpriseleader.com

Biocept Inc (NASDAQ:BIOC) shares gapped up before the market opened on Tuesday . The stock had previously closed at $0.75, ...

Biocept Enters Into Agreement with Reference-based Pricing Network Medical Cost Containment Professionals, LLC to Process Out-of-Network Claims

9d ago, source: YAHOO!

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with ...

Biocept Announces the Availability of 10,000 Specimen Collection Kits for RT-PCR COVID-19 Testing

11d ago, source: PR Newswire

PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide ...

Biocept receives Canadian patent entitled methods and reagents for signal amplification

1d ago, source: Pharmabiz

Biocept receives Canadian patent entitled methods and reagents for signal amplification: San Diego Thursday, July 2, 2020, 15:00 Hrs [IST] Biocept Inc, a leading commercial provid ...

Biocept makes available 10,000 nasopharyngeal specimen collection kits used in coronavirus testing

10d ago, source: Proactiveinvestors

Collected specimens will be shipped overnight to Biocept's San Diego lab with results returned to ordering physicians within 24 to 48 hours CEO Nall said the company expects its RT-PCR COVID-19 kits ...

Biocept’s Covid-19 Testing Capacity Puts It at the Head of the Pack

6d ago, source: Nasdaq

The micro-cap has manufactured 10,000 nasopharangeal swab collection kits, which will be available by 3Q to conduct PCR ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.